Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum

Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline ...

Gilead Sciences: From All-Time Highs To Higher Highs

Since my article from October, "What To Expect From Gilead in Q3 2025", Gilead Sciences' stock ( GILD) reached an all-time ...
Penticton Herald

Bernice’s story highlights B.C.’s new liver transplant guidelines for Indigenous patients

On Nov. 1, 2025, roughly three years and a month after Bernice’s death, the class complaint was settled and PHSA, BCTS and ...

Death notices and funeral announcements from Huddersfield Examiner this week

Each week we pay tribute to the loved ones remembered in our area with a funeral notice and online tribute page. To read the ...
Gastroenterology Advisor

IBD With PBC Confers Markedly High Risk for Colorectal, Hepatobiliary Malignancies

Patients with IBD and primary sclerosing cholangitis have markedly higher risks for colorectal and hepatobiliary cancers than those with isolated IBD or PSC.
Santé log

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

GENFIT is a biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases whose medical needs remain largely unmet. GENFIT is a pioneer in liver ...